Regeneron Pharmaceuticals Inc. buy Vassago1
Start price
30.05.25
/
50%
€460.00
Target price
30.05.26
-
Performance (%)
-5.43%
End price
07.06.25
€435.00
Summary
This prediction ended on 07.06.25 with a price of €435.00. With a performance of -5.43%, the BUY prediction by Vassago1 finished with a loss. Vassago1 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.320% | 3.320% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by Vassago1 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Buy Regeneron Pharmaceuticals Inc.